|
| |
|
Sify.com » Topics » Strides Arcolab
Strides Arcolab News
Indian stocks to watch-May 9 MUMBAI, May 9 (Reuters) - GLOBAL MARKETS ROUNDUP * Asian shares fell on Wednesday, as Greece struggled to form a government two days after elections, raising the risk that a hard-won bailout could be nullified. * U.S. stocks ended lower on Tuesday after political developments in Greece fanned concerns about Europe's fiscal health, but a late rally helped indexes cut losses to close well above
Fund managers see S&P action as a blessing in disguise
Markets remained subdued between 18th and 25th of this month on account of two negative news, namely Macquarie’s Asia hedge fund exiting its short positions in Indian single stock futures and
Sensex up 73 points, looks headed for another positive close
Strides gets US approvals for Methotrexate Injection
Onco Therapies Limited, a wholly owned subsidiary of pharmaceutical company Strides Arcolab Limited (Strides), on Friday announced that it has received US FDA approvals for Methotrexate Injection.
Strides Arcolab grows 48%
Bangalore, February 27, 2012: Strides Arcolab (Strides), a global pharmaceutical company, on Monday announced its financial results for the year ended December 31, 2011 where it recorded a 48% increase in growth.
Sebi rejects Rs 260-cr preferential warrant issue by Strides Arcolab
|
|
|
© Copyright Sify Technologies Ltd, 1998-2011. All rights reserved. India News Portal, Sify.com hosted at SifyHosting India's first Level 3 Internet Data Centre. Site optimized for Internet Explorer 5.5 and above. See Disclaimer |Privacy Policy &Parental Guidance on pornography |careers@sify |About Us |Feedback |Advertise | |
